Dr Ronald Dean Mulder, MD | |
17236 Sandgate Pl, West Olive, MI 49460-8508 | |
(616) 296-9222 | |
Not Available |
Full Name | Dr Ronald Dean Mulder |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology |
Location | 17236 Sandgate Pl, West Olive, Michigan |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699119412 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 4301028719 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Ronald Dean Mulder, MD 17236 Sandgate Pl, West Olive, MI 49460-8508 Ph: (616) 296-9222 | Dr Ronald Dean Mulder, MD 17236 Sandgate Pl, West Olive, MI 49460-8508 Ph: (616) 296-9222 |
News Archive
The U.S. Food and Drug Administration today published a new regulation defining the term "gluten-free" for voluntary food labeling. This will provide a uniform standard definition to help the up to 3 million Americans who have celiac disease, an autoimmune digestive condition that can be effectively managed only by eating a gluten free diet.
In his latest column, a collaboration between Kaiser Health News and the New Republic, Jonathan Cohn writes about the ongoing discourse surrounding the cost of reform.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.
According to Kalorama Information, the global advanced patient monitoring market is currently worth about $31.4 billion, inclusive of devices, peripherals, software, packaged services and other applications. The market has benefited from the demand to move to a more wireless and streamlined operation both within major health facilities and in the home treatment markets.
› Verified 7 days ago